Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Brookfield closes in on $9bn acquisition of Colonial Pipeline from KKR, CDPQ, and Shell
Brookfield closes in on $9bn acquisition of Colonial Pipeline from KKR, CDPQ, and Shell Brookfield Asset Management is nearing the completion of a $9bn+ acquisition of Colonial Pipeline, in what is set to become one of the largest private equity-backed infrastructure...
Bain Capital targets June exit as Virgin Australia IPO plans resurface for third time
Bain Capital targets June exit as Virgin Australia IPO plans resurface for third time Bain Capital is preparing to float Virgin Australia in a long-awaited IPO, targeting a June listing that could mark the private equity firm’s exit from one of its most high-profile...
Private equity trio weighs IPO exit from Spain’s $21.6bn MasOrange telecom giant
Private equity trio weighs IPO exit from Spain’s $21.6bn MasOrange telecom giant KKR, Cinven, and Providence Equity Partners are exploring an IPO of Spanish telecoms operator MasOrange, following a $21.6bn merger between Orange España and MásMóvil in 2022. The...